Cytokinetics, Incorporated Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • November 6th, 2017 • Cytokinetics Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 6th, 2017 Company Industry JurisdictionCytokinetics, Incorporated, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: